secwatch.observer — SEC 8-K summary
======================================

Issuer:     Grown Rogue International Inc. (GRUSF)
CIK:        0001463000
Form:       8-K
Filed at:   2026-08-25T19:50:50+00:00
Accession:  0001279569-26-000827
Event type: m_and_a
Sentiment:  positive
Materiality: 0.78
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Grown Rogue enters NY via JV, $15M financing commitment, plans PharmaCann NY acquisition
--------------------------------------------------------------------------------

- Grown Rogue New York JV: capital partner invests $10M for 49% preferred equity; Grown Rogue holds 51%.
- Planned purchase price ~$4.5M ($3M at regulatory approval); plus $5M drawable term loan at 15%, $9M secured loan to PCNY.
- Targets: 4 Verilife dispensaries (avg $1.7-2.0M monthly sales) and Hamptonburgh facility with 24,000 sq ft indoor + 16,000 sq ft greenhouse canopy.
- Preferred equity convertible to ~18.2M SVS (~7% dilution) at $0.55-0.76/share; commitment fee 300K shares + 0.901 warrants per $1 drawn.
- Expects NY operations cash-flow positive within 9 months, ~$600K monthly after-tax CF within 18 months; ~$20M annual cost reductions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1463000/000127956926000827/0001279569-26-000827-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1463000/000127956926000827/grownrogue8k.htm
  HTML page:      https://secwatch.observer/filing/0001279569-26-000827

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer